Skip to content

Mobile app for cardiovascular risk modification among diabetic patients

Randomized controlled study to assess effectiveness and acceptability of mobile app based interventional tool for cardiovascular disease self management and risk factor control among diabetic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038689
Enrollment
300
Registered
2021-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus

Interventions

Intervention1: Mobile app: Mobile app will be developed for cardiovascular risk reduction and patients will be using this app for self management Control Intervention1: Control group.: The patients wi

Sponsors

MGM Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosed cases of Type 2 Diabetes Mellitus Aged �18 years of age 2) Patients who agree to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1) Patients with Type 1 diabetes mellitus Pregnant women, including those with gestational diabetes 2) People with established coronary heart disease, cerebrovascular disease and peripheral vascular disease � Patients who do not agree to sign consent form

Design outcomes

Primary

MeasureTime frame
Development of a mobile app on assessment and preventive strategies (Pharmacological and Non-Pharmacological Intervention) for CVD risk modification among diabetic patients Effectiveness of mobile app based interventional tool for CVD self-management practices and risk factor reduction among diabetic patients Timepoint: 0,3 and 6 months

Secondary

MeasureTime frame
1. Impact of using CVD risk prediction app on prescribing practices for Type 2 diabetic patients with variable CVD risk profiles 2. Acceptability among the diabetic patients and physicians regarding usefulness of the mobile app for cardiovascular risk modification Timepoint: 0,3 and 6 months

Countries

India

Contacts

Public ContactDr Ipseeta Ray

MGM Institute of Health Sciences

ipseetamohanty@yahoo.co.in9819908498

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026